http://www.anpacbio.com/wp-content/uploads/2019/10/anpac_bio.svg 0 0 anpacbio http://www.anpacbio.com/wp-content/uploads/2019/10/anpac_bio.svg anpacbio2021-12-19 00:03:222022-01-18 20:04:18Development and evaluation of cancer differentiation analysis technology: a novel biophysics-based cancer screening method: Expert Review of Molecular Diagnostics: Vol 0, No 0
Sign up for the Anpac Bio newsletter and receive our latest news.
Anpac Technology USA (Anpac Bio)
3 Spring House Innovation Park, Suite 150
Ambler, PA 19002
Email: [email protected]
Phone Number: +1 (267) 810-6776
Anpac Bio-Medical Science Co., Ltd.
Anpac Bio is a biotechnology company focusing on early cancer screening and detection and marketing a suite of cancer detection tests, including CDA (Cancer differentiation analysis), bio-chemistry, immunology, and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented Cancer Differentiation Analysis (CDA) technology and proprietary cancer-detection device.